PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

39,980 stories, page 356 of 667

Advanced search
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06770582: Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06665100: PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06619509: A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06517693: Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06434272: Blood Flow Restriction Exercise in Patients With an Achilles Tendon Rupture

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06411210: Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05906537: SKB410 for Injection in Solid Tumors

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05889182: A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05739981: Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05050916: The Investigation of Vitamin D and Menstrual Cycles Trial, the inVitD Trial: A Phase II Clinical Trial

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04739800: Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04310007: Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04040634: Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES)

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03474718: Evaluating the Efficacy of Platelet-rich Plasma Therapy in the Treatment of Androgenic Alopecia

Study type: INTERVENTIONAL. Phase: EARLY_PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT02257528: Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT01747213: Bisnorcymserine in Healthy Adult Volunteers

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT01571752: Health Outcomes by Neighborhood - Baltimore

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT01316783: Genetics of Obesity, Diabetes, and Heart Disease in African Diaspora Populations

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT00588770: Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT00344188: Diagnosis and Treatment of Leishmania Infections

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT00077909: Study of Lung Proteins in Patients With Pneumonia

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT00001975: Study of Skin Tumors in Tuberous Sclerosis

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT00001204: Cardiovascular Evaluation of Patients With High Cholesterol and Normal Volunteers

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Cisen Pharmaceutical Ltd. Class A – SSE:603367

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What Are the Biggest Challenges Pharmaceutical Manufacturers Are Facing Today?

MarketScaleOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Approves Pluvicto for Early-Stage Metastatic Prostate Cancer

WebMDOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Amplia announces agreement with Lilly to test narmafotinib combination in lung cancer

BiotechDispatchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ORIC Pharmaceuticals (ORIC) Launches Pivotal Phase 3 Trial Amid Mixed Market Signals

GuruFocusOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Salicylic Acid Pharmaceutical Market to Double by 2035 on Dermatology API Demand

indexbox.ioOriginal source
🇪🇸Researchcnic.esTier 2 · Direct publisher

Circulation: El mayor estudio genético y de resonancia magnética realizado hasta la fecha descarta la existencia de una enfermedad del corazón

CNIC Spain CardiovascularOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ICYMI: FDA Clears Medicus to Begin Gorlin Syndrome SkinJect Trial

MyChesCoOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Mail-order pharmacy influencing FDA policy sells 'thousands' of abortion pills monthly

liveaction.orgOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moleculin Biotech Raises $9.3 Million Equity; Signs Placement, Purchase and Lock-Up Agreements

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day

marketwatch.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Korea biotech chiefs buy shares as FDA setbacks sink stocks - CHOSUNBIZ

ChosunbizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Korea bio chiefs buy shares as trial failures sink investor confidence - CHOSUNBIZ

ChosunbizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Otsuka Unveils Unprecedented Phase 3 VISIONARY Two-Year eGFR Results Demonstrating VOYXACT® (sibeprenlimab-szsi) Stabilizes Kidney Function Decline to Baseline Physiologic Rate, Fundamentally Altering Disease Progression in IgA Nephropathy

FinancialContentOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why is Krystal Biotech stock sliding today?

Investing.comOriginal source
🇪🇺Researchectrims.euTier 2 · Direct publisher

IACCTMS proposes roadmap for devising new, biologically based course descriptors for MS

ECTRIMS MSOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

San Diego Cancer Biotech BlossomHill Seeks Public Listing to Support Clinical Work

Briefs FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Non-Opioid Developer Latigo Biotherapeutics Files for Up to $288M Float as Lead Drug Nears Phase 3

Briefs FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Fujifilm and Taiho Pharmaceutical Enter into Strategic Partnership for Development of Next-Generation Antibody-Drug Conjugate (ADC) Manufacturing Technologies

markets.businessinsider.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Three Noteworthy Biotechs Just Reported Earnings — And Only One Recovered

Investor's Business DailyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ORIC® Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Updates

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AstraZeneca and Bristol Myers Squibb Held Merger Talks | PharmExec

Pharmaceutical ExecutiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Jazz Pharmaceuticals Announces Second Quarter 2026 Financial Results

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ORIC Starts Global Prostate Cancer Trial Expected to Enroll About 600

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ORIC® Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Updates

GlobeNewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Drug spending increasingly rewards pharmaceutical innovation over 'me-too' medicines

Medical XpressOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Claris Bio raises $118M to advance first-ever LSCD therapy

Glance by Eyes On EyecareOriginal source
🌍Researchuab.eduTier 2 · Direct publisher

Transformational $5 million gift to advance UAB O’Neal Cancer Center Clinical Trials Program

University of Alabama at BirminghamOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ozempic For Weight Loss: Is It Safe And What Do Experts Say?

ForbesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

4 FDA-Approved Weight Loss Medications, Recommended By Experts

ForbesOriginal source
🌍Mediaskpharmteco.comTier 3 · Secondary coverage

Lentiviral Vector Manufacturing CDMO Fact Sheet

SkpharmtecoOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Altimmune (ALT) Begins Enrollment in Phase 3 Trial Amid High Pri

GuruFocusOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Concerns Unapproved GLP-1 Drugs Used for Weight Loss Official - View OJoqVBGOb

FC BayernOriginal source
🌍Mediaskpharmteco.comTier 3 · Secondary coverage

AAV Manufacturing CDMO Fact Sheet

SkpharmtecoOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA panel backs 6 peptides despite its own scientists’ objections

MassLiveOriginal source
🌍discoverynews.google.comTier 2 · Trade media

An AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled.

BioPharma DiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The 2026 Forecast Revisited: Dealmaking, Direct-to-Patient and Patient Affordability

Pharmaceutical CommerceOriginal source